publicationMetadata:
  pmid: "25534823"
  title: "Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research → antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    
    This publication describes experimental laboratory research using:
    - Primary mouse astrocyte cultures (cell culture systems)
    - Nf1 optic glioma-bearing mice (animal models)
    - Pharmacologic inhibitors (genetic/chemical reagents)
    - In vitro and in vivo experimental approaches
    
    Expected tools include animal models (Nf1 knockout/mutant mice), primary cell cultures,
    and potentially computational tools for data analysis. The study involves both cell culture
    and animal model experiments with pharmacologic interventions.
  overallAssessment: |
    This is a clear laboratory research publication that should contain multiple research tools.
    The study uses primary mouse astrocyte cultures and Nf1 optic glioma-bearing mice for
    experimental work, indicating the presence of animal models and cell culture systems.
    The fact that no tools were initially mined suggests significant gaps in the mining patterns.

toolValidations: []

potentiallyMissedTools:
  - toolName: "Nf1 optic glioma-bearing mice"
    toolType: "animal_model"
    foundIn: "methods"
    contextSnippet: "Nf1 optic glioma–bearing mice were used to assess the effect of Akt and MEK inhibition on tumor volume, proliferation, and retinal ganglion cell dysfunction."
    whyMissed: "Animal model not captured - likely missing patterns for 'glioma-bearing mice' or Nf1-specific mouse models"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "Primary neonatal mouse astrocyte cultures"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Primary neonatal mouse astrocyte cultures were employed to determine the consequence of phosphatidylinositol-3 kinase (PI3K)/Akt and MEK inhibition on Nf1-deficient astrocyte growth."
    whyMissed: "Primary cell culture system not captured - missing patterns for 'primary astrocyte cultures'"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "Nf1-deficient astrocytes"
    toolType: "cell_line"
    foundIn: "results"
    contextSnippet: "Both MEK and Akt were hyperactivated in Nf1-deficient astrocytes in vitro and in Nf1 murine optic gliomas in vivo."
    whyMissed: "Genetically modified cell line not captured - missing patterns for 'deficient astrocytes' or knockout cell systems"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "Nf1 murine optic gliomas"
    toolType: "animal_model"
    foundIn: "results"
    contextSnippet: "Both MEK and Akt were hyperactivated in Nf1-deficient astrocytes in vitro and in Nf1 murine optic gliomas in vivo."
    whyMissed: "Tumor model not captured - missing patterns for 'murine optic gliomas' or Nf1-specific tumor models"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "PI3K inhibitor"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "Pharmacologic PI3K or Akt inhibition reduced Nf1-deficient astrocyte proliferation to wild-type levels, while PI3K inhibition decreased Nf1 optic glioma volume and proliferation."
    whyMissed: "Pharmacologic inhibitor not captured - missing patterns for specific kinase inhibitors"
    confidence: 0.80
    shouldBeAdded: Yes

  - toolName: "Akt inhibitor"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "Pharmacologic PI3K or Akt inhibition reduced Nf1-deficient astrocyte proliferation to wild-type levels"
    whyMissed: "Pharmacologic inhibitor not captured - missing patterns for Akt inhibitors"
    confidence: 0.80
    shouldBeAdded: Yes

  - toolName: "MEK inhibitor"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "Sustained MEK pharmacologic blockade also attenuated Nf1-deficient astrocytes as well as Nf1 optic glioma volume and proliferation."
    whyMissed: "Pharmacologic inhibitor not captured - missing patterns for MEK inhibitors or 'pharmacologic blockade'"
    confidence: 0.80
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "context_phrase"
    pattern: "\\b\\w+-bearing mice\\b"
    toolType: "animal_model"
    examples: ["Nf1 optic glioma-bearing mice"]
    reasoning: "Captures tumor-bearing or disease-bearing mouse models commonly used in cancer research"

  - patternType: "context_phrase"
    pattern: "primary \\w+ \\w+ cultures?"
    toolType: "cell_line"
    examples: ["Primary neonatal mouse astrocyte cultures"]
    reasoning: "Captures primary cell culture systems which are important research tools"

  - patternType: "context_phrase"
    pattern: "\\w+-deficient \\w+ (cells?|astrocytes?)"
    toolType: "cell_line"
    examples: ["Nf1-deficient astrocytes"]
    reasoning: "Captures genetically modified cell lines with gene knockouts or deficiencies"

  - patternType: "context_phrase"
    pattern: "murine \\w+ (gliomas?|tumors?)"
    toolType: "animal_model"
    examples: ["Nf1 murine optic gliomas"]
    reasoning: "Captures mouse tumor models used in cancer research"

  - patternType: "context_phrase"
    pattern: "pharmacologic(al)? \\w+ (inhibition|blockade)"
    toolType: "genetic_reagent"
    examples: ["Pharmacologic PI3K inhibition", "MEK pharmacologic blockade"]
    reasoning: "Captures pharmacological inhibitors used as research reagents"

  - patternType: "term"
    pattern: "(PI3K|Akt|MEK|mTOR) inhibitor"
    toolType: "genetic_reagent"
    examples: ["PI3K inhibitor", "Akt inhibitor", "MEK inhibitor"]
    reasoning: "Captures specific kinase inhibitors commonly used in cell signaling research"

  - patternType: "naming_convention"
    pattern: "\\bNf1[+-]?/?[+-]?\\b"
    toolType: "animal_model"
    examples: ["Nf1+/-", "Nf1-/-"]
    reasoning: "Captures standard mouse genetic nomenclature for Nf1 knockout/heterozygous mice"

observations:
  - resourceName: "Nf1-deficient astrocytes"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      Both MEK and Akt were hyperactivated in Nf1-deficient astrocytes in vitro compared to wild-type controls.
      This represents a key molecular phenotype of the cell line showing altered kinase signaling pathways.
    foundIn: "results"
    contextSnippet: "Both MEK and Akt were hyperactivated in Nf1-deficient astrocytes in vitro and in Nf1 murine optic gliomas in vivo."
    confidence: 0.95
    doi: "10.1093/neuonc/nou329"

  - resourceName: "Nf1-deficient astrocytes"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      PI3K or Akt inhibition reduced Nf1-deficient astrocyte proliferation to wild-type levels,
      demonstrating that these pathways are critical for the enhanced proliferation phenotype.
    foundIn: "results"
    contextSnippet: "Pharmacologic PI3K or Akt inhibition reduced Nf1-deficient astrocyte proliferation to wild-type levels"
    confidence: 0.90
    doi: "10.1093/neuonc/nou329"

  - resourceName: "Nf1 murine optic gliomas"
    resourceType: "Animal Model"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      PI3K inhibition decreased Nf1 optic glioma volume and proliferation in vivo.
      This demonstrates the therapeutic potential of targeting this pathway in NF1-associated tumors.
    foundIn: "results"
    contextSnippet: "while PI3K inhibition decreased Nf1 optic glioma volume and proliferation."
    confidence: 0.95
    doi: "10.1093/neuonc/nou329"

  - resourceName: "Nf1 murine optic gliomas"
    resourceType: "Animal Model"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      Sustained MEK pharmacologic blockade attenuated Nf1 optic glioma volume and proliferation.
      MEK inhibitory effects resulted from p90RSK-mediated, Akt-independent mTOR activation.
    foundIn: "results"
    contextSnippet: "Sustained MEK pharmacologic blockade also attenuated Nf1-deficient astrocytes as well as Nf1 optic glioma volume and proliferation."
    confidence: 0.90
    doi: "10.1093/neuonc/nou329"

  - resourceName: "Nf1 optic glioma-bearing mice"
    resourceType: "Animal Model"
    observationType: "Nervous System"
    observationTypeOntologyId: "MP:0003633"
    details: |
      Both PI3K and MEK inhibition reduced optic glioma-associated retinal ganglion cell loss
      and nerve fiber layer thinning, indicating neuroprotective effects beyond tumor growth inhibition.
    foundIn: "results"
    contextSnippet: "Finally, both PI3K and MEK inhibition reduced optic glioma–associated retinal ganglion cell loss and nerve fiber layer thinning."
    confidence: 0.85
    doi: "10.1093/neuonc/nou329"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 7
  newPatternsCount: 7
  observationsExtracted: 5
  observationsByType:
    Cellular: 2
    Tumor Growth: 2
    Nervous System: 1
  majorIssuesFound: |
    - No tools were initially mined despite this being a clear laboratory research publication
    - Multiple animal models and cell culture systems were completely missed
    - Pharmacologic inhibitors used as research reagents were not captured
    - Mining patterns appear inadequate for capturing NF1-specific research tools
    - Standard laboratory research terminology was not recognized
  recommendations: |
    This publication represents a significant failure of the mining system to capture obvious research tools.
    All 7 potentially missed tools should be added to the database as they represent genuine research tools
    used in experimental procedures. The suggested patterns should be implemented to improve future mining
    of similar publications. This case highlights the need for better coverage of:
    1. Animal tumor models and disease-bearing mice
    2. Primary cell culture systems
    3. Genetically modified cell lines
    4. Pharmacologic inhibitors as research reagents
    5. Standard mouse genetic nomenclature
    The observations extracted demonstrate clear experimental findings that should be preserved in the database.
